Absence of mutations in cereblon (CRBN) and DNA damage-binding protein 1 (DDB1) genes and significance for IMiD therapy

A Thakurta; A K Gandhi; M F Waldman; C Bjorklund; Y Ning; D Mendy; P Schafer; A Lopez-Girona; S Lentzsch; S A Schey; Y Calle; R Chelliah; R Z Orlowski; A Madan; H Avet-Loiseau; R Chopra

doi:10.1038/leu.2013.315

Absence of mutations in cereblon (CRBN) and DNA damage-binding protein 1 (DDB1) genes and significance for IMiD therapy

A Thakurta, A K Gandhi, M F Waldman, C Bjorklund, Y Ning, D Mendy, P Schafer, A Lopez-Girona, S Lentzsch, S A Schey, Y Calle, R Chelliah, R Z Orlowski, A Madan, H Avet-Loiseau, R Chopra

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1129-31
Number of pages	3
Journal	Leukemia
Volume	28
Issue number	5
DOIs	https://doi.org/10.1038/leu.2013.315
Publication status	Published - May 2014

Keywords

Adjuvants, Immunologic
DNA-Binding Proteins
Humans
Mutation
Peptide Hydrolases
Thalidomide

Access to Document

10.1038/leu.2013.315Licence: CC BY-NC-ND

Yolanda Calle
- yolanda.calle-patinoroehampton.acuk
- School of Life and Health Sciences - Senior Lecturer
- Centre for Integrated Research in Life and Health Sciences
Person: Academic

Cite this

Thakurta, A., Gandhi, A. K., Waldman, M. F., Bjorklund, C., Ning, Y., Mendy, D., Schafer, P., Lopez-Girona, A., Lentzsch, S., Schey, S. A., Calle, Y., Chelliah, R., Orlowski, R. Z., Madan, A., Avet-Loiseau, H., & Chopra, R. (2014). Absence of mutations in cereblon (CRBN) and DNA damage-binding protein 1 (DDB1) genes and significance for IMiD therapy. Leukemia, 28(5), 1129-31. https://doi.org/10.1038/leu.2013.315

@article{ca7a013b65f94c6b8af60b09987387d8,

title = "Absence of mutations in cereblon (CRBN) and DNA damage-binding protein 1 (DDB1) genes and significance for IMiD therapy",

keywords = "Adjuvants, Immunologic, DNA-Binding Proteins, Humans, Mutation, Peptide Hydrolases, Thalidomide",

author = "A Thakurta and Gandhi, {A K} and Waldman, {M F} and C Bjorklund and Y Ning and D Mendy and P Schafer and A Lopez-Girona and S Lentzsch and Schey, {S A} and Y Calle and R Chelliah and Orlowski, {R Z} and A Madan and H Avet-Loiseau and R Chopra",

year = "2014",

month = may,

doi = "10.1038/leu.2013.315",

language = "English",

volume = "28",

pages = "1129--31",

journal = "Leukemia",

issn = "1476-5551",

publisher = "Macmillan Press",

number = "5",

}

Thakurta, A, Gandhi, AK, Waldman, MF, Bjorklund, C, Ning, Y, Mendy, D, Schafer, P, Lopez-Girona, A, Lentzsch, S, Schey, SA, Calle, Y, Chelliah, R, Orlowski, RZ, Madan, A, Avet-Loiseau, H & Chopra, R 2014, 'Absence of mutations in cereblon (CRBN) and DNA damage-binding protein 1 (DDB1) genes and significance for IMiD therapy', Leukemia, vol. 28, no. 5, pp. 1129-31. https://doi.org/10.1038/leu.2013.315

TY - JOUR

T1 - Absence of mutations in cereblon (CRBN) and DNA damage-binding protein 1 (DDB1) genes and significance for IMiD therapy

AU - Thakurta, A

AU - Gandhi, A K

AU - Waldman, M F

AU - Bjorklund, C

AU - Ning, Y

AU - Mendy, D

AU - Schafer, P

AU - Lopez-Girona, A

AU - Lentzsch, S

AU - Schey, S A

AU - Calle, Y

AU - Chelliah, R

AU - Orlowski, R Z

AU - Madan, A

AU - Avet-Loiseau, H

AU - Chopra, R

PY - 2014/5

Y1 - 2014/5

KW - Adjuvants, Immunologic

KW - DNA-Binding Proteins

KW - Humans

KW - Mutation

KW - Peptide Hydrolases

KW - Thalidomide

U2 - 10.1038/leu.2013.315

DO - 10.1038/leu.2013.315

M3 - Article

C2 - 24166296

SN - 1476-5551

VL - 28

SP - 1129

EP - 1131

JO - Leukemia

JF - Leukemia

IS - 5

ER -

Absence of mutations in cereblon (CRBN) and DNA damage-binding protein 1 (DDB1) genes and significance for IMiD therapy

Keywords

Access to Document

Profiles

Yolanda Calle

Cite this